ESTIMATION OF A CHROMIUM INHALATION REFERENCE CONCENTRATION USING THE BENCHMARK DOSE METHOD - A CASE-STUDY

被引:13
作者
MALSCH, PA [1 ]
PROCTOR, DM [1 ]
FINLEY, BL [1 ]
机构
[1] CHEMRISK MCLAREN HART GRP,ENVIRONM ENGN,ALAMEDA,CA 94501
关键词
D O I
10.1006/rtph.1994.1036
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The benchmark dose (BD) method has been proposed as an alternative to the NOAEL/UF method for setting reference levels. The BD is the 95% lower confidence limit on a dose corresponding to a 10% increase (or relative change) in an adverse effect. A case study exploring the suitability of the current Cr(III) and Cr(VI) inhalation toxicity data bases to the BD approach is presented. Because chromic acid mists, typical of many occupational Cr(VI) exposures, present a toxicological profile different from that of Cr(VI) particulates, representative of environmental exposures, Cr(VI) particulate data were evaluated separately from Cr(VI) acidic mist data. The current Cr(III) and Cr(VI) acidic mist data bases proved inadequate for BD analysis due to data and/or study quality limitations. Benchmark reference concentrations (RfCs) for particulate Cr(VI) ranging from 0.34 mu g/m(3) (for lactate dehydrogenase (LDH) in bronchoalveolar lavage fluid (BALF)) to 1.4 mu g/m(3) (for increased lung weights) are derived from data taken from U. Glaser et al. (Arch. Toxicol. 57, 250-256, 1985) and U. Glaser et al. (Environmental Hygiene II, Springer-Verlag, Berlin/New York, 1990). A Cr(VI) particulate RfC of 0.34 mu g/m(3) based upon LDH in BALF as the critical effect is proposed. This value may be viewed as conservative since it represents the 95% lower confidence limit on the dose associated with a 10% increase in response for a sensitive endpoint and has appropriate dosimetric adjustments and uncertainty factors incorporated. (C) 1994 Academic Press, Inc.
引用
收藏
页码:58 / 82
页数:25
相关论文
共 84 条
[1]   ESTIMATION OF POTENTIAL HEALTH-EFFECTS FROM ACUTE EXPOSURE TO HYDROGEN-FLUORIDE USING A BENCHMARK DOSE APPROACH [J].
ALEXEEFF, GV ;
LEWIS, DC ;
RAGLE, NL .
RISK ANALYSIS, 1993, 13 (01) :63-69
[2]  
AXELSSON G, 1980, BRIT J IND MED, V37, P121
[3]   AN INVIVO HAMSTER BIOASSAY TO ASSESS THE TOXICITY OF PARTICULATES FOR THE LUNGS [J].
BECK, BD ;
BRAIN, JD ;
BOHANNON, DE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 66 (01) :9-29
[4]   THE PULMONARY TOXICITY OF AN ASH SAMPLE FROM THE MT ST HELENS VOLCANO [J].
BECK, BD ;
BRAIN, JD ;
BOHANNON, DE .
EXPERIMENTAL LUNG RESEARCH, 1981, 2 (04) :289-301
[5]   ASSESSMENT OF PROGRESSION OF ASBESTOSIS IN THE SHEEP MODEL BY BRONCHOALVEOLAR LAVAGE AND PULMONARY-FUNCTION TESTS [J].
BEGIN, R ;
ROLAPLESZCZYNSKI, M ;
MASSE, S ;
NADEAU, D ;
DRAPEAU, G .
THORAX, 1983, 38 (06) :449-457
[6]  
BEGIN R, 1983, RES COMMUN CHEM PATH, V40, P267
[7]  
BENSON JM, 1986, FUNDAM APPL TOXICOL, V7, P240
[8]  
BIGBY TD, 1985, AM REV RESPIR DIS, V132, P590
[9]   EFFECTS OF HEAVY-METAL IONS ON SELECTED OXIDATIVE METABOLIC PROCESSES IN RAT ALVEOLAR MACROPHAGES [J].
CASTRANOVA, V ;
BOWMAN, L ;
REASOR, MJ ;
MILES, PR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 53 (01) :14-23
[10]  
CRUMP K, 1985, TOXICOLOGICAL RISK A, V1